Atlas Trials

PHARMENTERPRISES LLC

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch PHARMENTERPRISES LLC

RecordFirmDate
Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis (NCT06391164)PHARMENTERPRISES LLC2024-04-01
Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Ascending Doses of XC243 After Single and Multiple Oral Administration in Healthy Volunteers. (NCT05628116)PHARMENTERPRISES LLC2022-09-28
Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19 (NCT05516550)PHARMENTERPRISES LLC2022-08-01
Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia (NCT04527354)PHARMENTERPRISES LLC2020-09-01
Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI (NCT03830905)PHARMENTERPRISES LLC2019-01-31
Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections (NCT03455491)PHARMENTERPRISES LLC2018-02-12
Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers (NCT03459391)PHARMENTERPRISES LLC2017-05-22
XC8 in the Treatment of Patients With Bronchial Asthma (NCT03450434)PHARMENTERPRISES LLC2016-09-20
XC8 in the Treatment of Patients With Acute Respiratory Viral Infection (NCT03441373)PHARMENTERPRISES LLC2016-02-03
Study to Assess Safety, Tolerability and Pharmacokinetics of Treamid in Healthy Volunteers (NCT04428593)PHARMENTERPRISES LLC2016-01-25
XC8 Safety, Tolerability and Pharmacokinetics in Healthy Volunteers (NCT03441815)PHARMENTERPRISES LLC2015-02-14

Track PHARMENTERPRISES LLC automatically

Every clearance here is in the API, with alerts when new ones post.